Effects of the Serine Protease Inhibitor RBmTI-A in an Experimental Mouse Model of Chronic Allergic Pulmonary Inflammation

Overview

Journal Sci Rep

Specialty Science

Date 2019 Sep 4

PMID 31477763

Citations 5

Authors

Ariana Correa Florencio

Robson S de Almeida

Fernanda M Arantes-Costa

Beatriz M Saraiva-Romanholo

Adriana F Duran

Sergio D Sasaki

Milton A Martins

Fernanda D T Q S Lopes

Iolanda F L C Tiberio

Edna A Leick

Affiliations

Soon will be listed here.

Abstract

To evaluate whether a recombinant serine protease inhibitor (rBmTI-A) modulates inflammation in an experimental model of chronic allergic lung inflammation. Balb/c mice were divided into four groups: SAL (saline), OVA (sensitized with ovalbumin), SAL + rBmTI-A (control treated with rBmTI-A) and OVA + rBmTI-A (sensitized with ovalbumin and treated with rBmTI-A). The animals received an intraperitoneal injection of saline or ovalbumin, according to the group. The groups received inhalation with saline or ovalbumin and were treated with rBmTI-A or saline by nasal instillation. After 29 days, we evaluated the respiratory mechanics; bronchoalveolar lavage fluid (BALF); cytokines; MMP-9, TIMP-1; eosinophils; collagen and elastic fibre expression in the airways; and the trypsin-like, MMP-1, and MMP-9 lung tissue proteolytic activity. Treatment with rBmTI-A reduced the trypsin-like proteolytic activity, the elastance and resistance maximum response, the polymorphonuclear cells, IL-5, IL-10, IL-13 and IL-17A in the BALF, the expression of IL-5, IL-13, IL-17, CD4+, MMP-9, TIMP-1, eosinophils, collagen and elastic fibres in the airways of the OVA + rBmTI-A group compared to the OVA group (p < 0.05). rBmTI-A attenuated bronchial hyperresponsiveness, inflammation and remodelling in this experimental model of chronic allergic pulmonary inflammation. This inhibitor may serve as a potential therapeutic tool for asthma treatment.

Citing Articles

Effects of plant protease inhibitors (Pep-3-EcTI, Pep-BbKI, and Pep-BrTI) versus corticosteroids on inflammation, remodeling, and oxidative stress in an asthma-COPD (ACO) model.

Joao J, Barbosa J, da Silva L, Fukuzaki S, de Campos E, do Nascimento Camargo L Front Pharmacol. 2024; 15:1282870.

PMID: 38774212 PMC: 11106483. DOI: 10.3389/fphar.2024.1282870.

The Role of the Nuclear Factor-Kappa B (NF-κB) Pathway in SARS-CoV-2 Infection.

Kesika P, Thangaleela S, Sisubalan N, Radha A, Sivamaruthi B, Chaiyasut C Pathogens. 2024; 13(2).

PMID: 38392902 PMC: 10892479. DOI: 10.3390/pathogens13020164.

Effects of a Peptide Derived from the Primary Sequence of a Kallikrein Inhibitor Isolated from (pep-BbKI) in an Asthma-COPD Overlap (ACO) Model.

da Silva L, Barbosa J, Joao J, Fukuzaki S, do Nascimento Camargo L, Dos Santos T Int J Mol Sci. 2023; 24(14).

PMID: 37511021 PMC: 10379932. DOI: 10.3390/ijms241411261.

Tick Salivary Kunitz-Type Inhibitors: Targeting Host Hemostasis and Immunity to Mediate Successful Blood Feeding.

Jmel M, Voet H, Araujo R, Tirloni L, Sa-Nunes A, Kotsyfakis M Int J Mol Sci. 2023; 24(2).

PMID: 36675071 PMC: 9865953. DOI: 10.3390/ijms24021556.

Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2.

Catanzaro M, Fagiani F, Racchi M, Corsini E, Govoni S, Lanni C Signal Transduct Target Ther. 2020; 5(1):84.

PMID: 32467561 PMC: 7255975. DOI: 10.1038/s41392-020-0191-1.

References

Nishioka T, Uchida K, Meno K, Ishii T, Aoki T, Imada Y . Alpha-1-antitrypsin and complement component C7 are involved in asthma exacerbation. Proteomics Clin Appl. 2010; 2(1):46-54. DOI: 10.1002/prca.200780065. View

Leckie M, Ten Brinke A, Khan J, Diamant Z, OConnor B, Walls C . Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet. 2001; 356(9248):2144-8. DOI: 10.1016/s0140-6736(00)03496-6. View

Royce S, Cheng V, Samuel C, Tang M . The regulation of fibrosis in airway remodeling in asthma. Mol Cell Endocrinol. 2012; 351(2):167-75. DOI: 10.1016/j.mce.2012.01.007. View

Menzies-Gow A, Flood-Page P, Sehmi R, Burman J, Hamid Q, Robinson D . Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics. J Allergy Clin Immunol. 2003; 111(4):714-9. DOI: 10.1067/mai.2003.1382. View

Lourenco J, Neves L, Olivo C, Duran A, Almeida F, Arantes P . A treatment with a protease inhibitor recombinant from the cattle tick (Rhipicephalus Boophilus microplus) ameliorates emphysema in mice. PLoS One. 2014; 9(6):e98216. PMC: 4041648. DOI: 10.1371/journal.pone.0098216. View

Arantes-Costa F, Zoriki S, Santos M, Kobata C, Vieira J, Martins M . Effects of ventilation, humidity and temperature on airway responsiveness to methacholine in rats. Eur Respir J. 2002; 19(6):1008-14. DOI: 10.1183/09031936.02.00232402. View

Fernandez-Rodriguez S, Ford W, Broadley K, Kidd E . Establishing the phenotype in novel acute and chronic murine models of allergic asthma. Int Immunopharmacol. 2008; 8(5):756-63. DOI: 10.1016/j.intimp.2008.01.025. View

Zijlstra G, Ten Hacken N, Hoffmann R, van Oosterhout A, Heijink I . Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells. Eur Respir J. 2011; 39(2):439-45. DOI: 10.1183/09031936.00017911. View

Lambrecht B, Hammad H . The immunology of asthma. Nat Immunol. 2014; 16(1):45-56. DOI: 10.1038/ni.3049. View

10.

Ishizaki M, Tanaka H, Kajiwara D, Toyohara T, Wakahara K, Inagaki N . Nafamostat mesilate, a potent serine protease inhibitor, inhibits airway eosinophilic inflammation and airway epithelial remodeling in a murine model of allergic asthma. J Pharmacol Sci. 2008; 108(3):355-63. DOI: 10.1254/jphs.08162fp. View

11.

Kita H, Sur S, Hunt L, Edell E, Weiler D, Swanson M . Cytokine production at the site of disease in chronic eosinophilic pneumonitis. Am J Respir Crit Care Med. 1996; 153(4 Pt 1):1437-41. DOI: 10.1164/ajrccm.153.4.8616578. View

12.

Sasaki S, Tanaka A . rBmTI-6, a Kunitz-BPTI domain protease inhibitor from the tick Boophilus microplus, its cloning, expression and biochemical characterization. Vet Parasitol. 2008; 155(1-2):133-41. DOI: 10.1016/j.vetpar.2008.03.031. View

13.

Lourenco J, Ito J, Cervilha D, Sales D, Riani A, Suehiro C . The tick-derived rBmTI-A protease inhibitor attenuates the histological and functional changes induced by cigarette smoke exposure. Histol Histopathol. 2017; 33(3):289-298. DOI: 10.14670/HH-11-927. View

14.

Camelier A, Winter D, Jardim J, Barboza C, Cukier A, Miravitlles M . [Alpha-1 antitrypsin deficiency: diagnosis and treatment]. J Bras Pneumol. 2008; 34(7):514-27. DOI: 10.1590/s1806-37132008000700012. View

15.

Righetti L, Galaverna G, DallAsta C . Group detection of DON and its modified forms by an ELISA kit. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2016; 34(2):248-254. DOI: 10.1080/19440049.2016.1265671. View

16.

Tanaka A, ANDREOTTI R, Gomes A, Torquato R, Sampaio M, Sampaio C . A double headed serine proteinase inhibitor--human plasma kallikrein and elastase inhibitor--from Boophilus microplus larvae. Immunopharmacology. 1999; 45(1-3):171-7. DOI: 10.1016/s0162-3109(99)00074-0. View

17.

Monteseirin J, Galindo P, Perez J, Bobadilla P, Conde J . Plasma kallikrein amidolytic activity in bronchial asthma. Allergol Immunopathol (Madr). 1992; 20(5):211-4. View

18.

Walters E, Ward C, Li X . Bronchoalveolar lavage in asthma research. Respirology. 1996; 1(4):233-45. DOI: 10.1111/j.1440-1843.1996.tb00039.x. View

19.

Asaduzzaman M, Nadeem A, Arizmendi N, Davidson C, Nichols H, Abel M . Functional inhibition of PAR2 alleviates allergen-induced airway hyperresponsiveness and inflammation. Clin Exp Allergy. 2015; 45(12):1844-55. DOI: 10.1111/cea.12628. View

20.

Atkinson J, Senior R . Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol. 2002; 28(1):12-24. DOI: 10.1165/rcmb.2002-0166TR. View